|
Volumn 24, Issue 1, 2011, Pages e1-e15
|
Meeting report from the 7th international melanoma congress, Sydney, November, 2010
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE KINASE INHIBITOR;
B RAF KINASE;
BRAF PROTEIN, HUMAN;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
PROTEIN KINASE INHIBITOR;
ANIMAL MODEL;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CANCER RESEARCH;
CANCER STEM CELL;
DERMATOLOGIST;
EPITHELIAL MESENCHYMAL TRANSITION;
HUMAN;
MEDICAL ONCOLOGIST;
MEDICAL SOCIETY;
MELANOMA;
MELANOMA CELL;
MOLECULARLY TARGETED THERAPY;
NONHUMAN;
PHENOTYPE;
SURGEON;
ANIMAL;
AUSTRALIA;
CLINICAL TRIAL (TOPIC);
CONFERENCE PAPER;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG SCREENING;
GENETICS;
IMMUNOTHERAPY;
METABOLISM;
MOUSE;
ORGANIZATION;
PATHOLOGY;
ZEBRA FISH;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
CONGRESSES AS TOPIC;
DISEASE MODELS, ANIMAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
IMMUNOTHERAPY;
MELANOMA;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
NEOPLASTIC STEM CELLS;
NEW SOUTH WALES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS B-RAF;
ZEBRAFISH;
|
EID: 79955021779
PISSN: 17551471
EISSN: 1755148X
Source Type: Journal
DOI: 10.1111/j.1755-148X.2010.00811.x Document Type: Article |
Times cited : (13)
|
References (0)
|